Schonfeld Strategic Advisors LLC Arcturus Therapeutics Holdings Inc. Transaction History

Schonfeld Strategic Advisors LLC

$15.2 Billion
Q3 2025

A detailed history of Schonfeld Strategic Advisors LLC transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 667,827 shares of ARCT stock, worth $4.86 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

667,827

Previous 784,407 14.86%

Holding current value

$4.86 Million

Previous $10.2 Million 20.61%

% of portfolio

0.08%

Previous 0.08%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$11.39 - $22.17 $1.33 Million - $2.58 Million	-116,580 Reduced 14.86%	667,827 $12.3 Million
Q2 2025 Aug 14, 2025	SELL	$8.91 - $14.41 $368,508 - $595,983	-41,359 Reduced 5.01%	784,407 $10.2 Million
Q1 2025 May 15, 2025	SELL	$10.59 - $20.83 $246,905 - $485,651	-23,315 Reduced 2.75%	825,766 $8.74 Million
Q4 2024 Feb 14, 2025	BUY	$14.82 - $25.48 $7.11 Million - $12.2 Million	479,482 Added 129.73%	849,081 $14.4 Million
Q3 2024 Nov 14, 2024	BUY	$18.08 - $25.38 $1.56 Million - $2.19 Million	86,179 Added 30.41%	369,599 $8.58 Million

Q2 2024 Aug 14, 2024	SELL	$24.35 - $44.39 $1.54 Million - $2.8 Million	-63,074 Reduced 18.2%	283,420 $6.9 Million
Q1 2024 May 15, 2024	SELL	$31.23 - $42.99 $1.72 Million - $2.36 Million	-54,987 Reduced 13.7%	346,494 $11.7 Million
Q4 2023 Feb 14, 2024	BUY	$17.71 - $32.97 $5.21 Million - $9.7 Million	294,325 Added 274.67%	401,481 $12.7 Million
Q3 2023 Nov 14, 2023	BUY	$25.44 - $37.35 $2.73 Million - $4 Million	107,156 New	107,156 $2.74 Million
Q3 2022 Nov 14, 2022	SELL	$13.05 - $22.13 $2.95 Million - $5 Million	-226,030 Reduced 84.47%	41,567 $616,000
Q2 2022 Aug 15, 2022	BUY	$12.26 - $31.17 $2.35 Million - $5.97 Million	191,501 Added 251.66%	267,597 $4.21 Million
Q1 2022 May 16, 2022	BUY	$17.64 - $39.57 $358,938 - $805,170	20,348 Added 36.5%	76,096 $2.05 Million
Q4 2021 Feb 14, 2022	SELL	$34.2 - $47.56 $1.53 Million - $2.13 Million	-44,879 Reduced 44.6%	55,748 $2.06 Million
Q3 2021 Nov 16, 2021	BUY	$27.88 - $58.25 $2.15 Million - $4.49 Million	77,095 Added 327.62%	100,627 $4.81 Million
Q2 2021 Aug 16, 2021	BUY	$25.79 - $42.11 $111,515 - $182,083	4,324 Added 22.51%	23,532 $796,000
Q1 2021 May 17, 2021	SELL	$38.75 - $86.92 $622,325 - $1.4 Million	-16,060 Reduced 45.54%	19,208 $793,000
Q4 2020 Feb 16, 2021	SELL	$34.61 - $123.66 $4.47 Million - $16 Million	-129,102 Reduced 78.54%	35,268 $1.53 Million
Q3 2020 Nov 16, 2020	BUY	$37.49 - $63.19 $5.43 Million - $9.16 Million	144,933 Added 745.66%	164,370 $7,000
Q2 2020 Aug 14, 2020	BUY	$12.66 - $58.27 $246,072 - $1.13 Million	19,437 New	19,437 $908,000

Others Institutions Holding ARCT

# of Institutions

173

Shares Held

26M

Call Options Held

2.32M

Put Options Held

866K

View Full List

About Arcturus Therapeutics Holdings Inc.

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $193M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

More about ARCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account

Schonfeld Strategic Advisors LLC Arcturus Therapeutics Holdings Inc. Transaction History